Rafael Nadal had one of the greatest tennis careers the game has ever seen. He also spent nearly all of it in pain. Between his first French Open win in 2005 and retirement in 2024, the Spaniard won 22 Grand Slam singles titles - the second-highest total of any man. He was part of the 'Big Three' era, where he, Roger Federer and Novak Djokovic carved up the sport's biggest prizes and thrilled fans. But a chronic foot injury meant Nadal had to find different ways just to get through matches, let alone win them. In a new Netflix series, the 39-year-old opens up about the risks he took with his health in order to achieve greatness. "I've had to make decisions about my health, where you are on the borderline between right or wrong," Nadal said. "But if I hadn't explored all that, I probably would have had 10 fewer Grand Slams. I'm not saying one or two, I'm saying 10 or 12. This is the reality." In 2005 the long-haired, muscular teenage sensation announced himself to the world by winning the French Open at his first attempt, beating world number one Roger Federer in the semi-finals on his 19th birthday. He finished that season ranked second in the world, having won 11 singles titles. However, it was also the year Nadal's injury struggle began in earnest. After breaking his left foot during his Madrid Open final victory, Nadal was diagnosed with a rare degenerative condition called Mueller-Weiss syndrome., external Speaking to the BBC World Service's Sporting Witness programme, Nadal said the foot injury was "the origin of all my problems". "I had to stay over-positive, over-determined, always ready to try to find a solution to keep being competitive and find a way to be on court again," he said. "I went through, a couple of times in my career, a long process of injuries, but I think I was ready to accept that moment, to tolerate the frustration and to keep working with hope and passion. "The key was the suffering was less than than my passion and my happiness for what I...

文章提及标的 华海药业 -- 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

意大利央行行长法比奥・帕内塔于周五表示，人工智能能够显著改善该国劳动生产率偏低的现状。 帕内塔在意大利央行年度大会上发表了上述讲话。 他称，若人工智能普及节奏偏慢，意大利劳动生产率每年可提升 0.2 个百分点；倘若技术落地速度快、应用范围广，年度增幅将超过 1 个百分点。 他提出，意大利需壮大风险投资与私募行业，以此扶持人工智能创新发展。 帕内塔指出，目前意大利 30% 的企业已使用人工智能，但深度应用该技术的企业仅约 5%。 他补充道，从国际水平来看，意大利人工智能普及率偏低，亟需出台公共政策加以推动。 帕内塔表示，意大利央行已与全球头部人工智能技术研发企业开展对接，近期也已联合各大银行，就人工智能落地应用展开磋商。 责任编辑：郭明煜

法国外交部长巴罗29日宣布，已要求法国检方调查参加“全球坚韧船队”的法国活动人士遭暴力对待一事。 巴罗当天在接受法国公共电台采访时说，根据一份来自法国驻土耳其外交官的报告，参加“全球坚韧船队”的法国公民遭受性暴力、暴露于寒冷环境中并遭到殴打和反复羞辱。这些行为可能构成刑事犯罪，此事已交由法国司法系统处理。 以色列海军18日上午拦截了试图驶往加沙地带的“全球坚韧船队”，该船队从土耳其南部起航，试图突破以色列对加沙地带的海上封锁，向加沙地带民众运送人道主义援助物资。 以色列国家安全部长本-格维尔20日在社交媒体上发布视频，嘲讽被扣活动人士，引发国际社会广泛批评。视频片段显示，数十名活动人士在以色列南部阿什杜德港口设施内被集中扣押。他们被要求跪在地上，双手被反绑，头朝地面，四周都是荷枪实弹的以方人员。 巴罗23日在社交媒体发文宣布，本-格维尔即日起被禁止入境法国。(新华社)

泰恩康公告，控股子公司江苏博创园生物医药科技有限公司组织开展的CKBA乳膏联合窄谱中波紫外线在2-12岁儿童非节段型白癜风受试者中的安全耐受性、疗效和药代动力学特征的多中心、随机、双盲、安慰剂对照II期临床试验完成首例受试者入组。

格隆汇5月29日丨以色列国防军当地时间29日证实，以国防军和安全部门前日打死了巴勒斯坦伊斯兰抵抗运动（哈马斯）“加沙城旅”副指挥官、宰通营指挥官阿马德·哈桑·哈辛·阿斯利姆。

信达生物股价大涨10.02%。 又一起创新药百亿美元授权大单落地。 5月29日上午，信达生物（01801.HK）宣布与辉瑞公司达成总额为105亿美元的交易，本次合作涵盖由12个项目构成的肿瘤产品组合，包括8个信达生物的早期管线，及4个将由辉瑞提议的全新（de novo）项目。 这次交易下，信达生物将获得的首付款为6.5亿美元，并有资格获得最高可达98.5亿美元的研发、监管与商业化里程碑付款。 受上述消息提振，信达生物5月29日上午股价大涨10.02%。 在信达生物与辉瑞达成交易之前，同样在本月，恒瑞医药也与百时美施贵宝公司（即“BMS”）达成全球战略合作，共同推进13款早期研发项目，潜在总交易额可达152亿美元。 医药魔方数据显示，2025年中国创新药对外授权总额达1357亿美元；2026年第一季度，中国创新药出海交易总金额达到596亿美元，接近去年全年一半。 中国医药创新成为全球医药创新策源地之一，越来越多跨国药企将中国视为关键的外部创新资产来源地。对于中国创新药来说，授权交易数量以及金额看似繁荣，但不少交易仍是单向对外许可模式，即最后能赚到的更多是短期首付款与里程碑收益。在创新药收益分配中，中国药企享受到的仍是小头，同时可能还无法真正积累海外临床、合规与商业化能力。 近日，在2026年ChinaBio生物医药产业国际合作大会上，美富律师事务所上海和香港办公室管理合伙人孙川表示，“对外许可”是一种较为直接的交易模式，对于资金紧张或希望在不承担研发风险的情况下获得资金的公司而言，这种模式极具吸引力。然而，一旦相关资产被授权，尤其是授权到中国以外的市场，生物科技公司往往需要在一定程度上让渡对于该资产的控制权、灵活性和治理权。 中国创新药如何避免沦为“卖青苗”，日益受到关注。 在信达生物与辉瑞公司的交易上，交易模式试图做出一些尝试，此次合作模式包括许可、共同开发及共同商业化（Co-Co）。其中，信达与辉瑞将在全球范围内共同开发4个关键项目，并共同承担开发成本。同时，双方将在美国及欧洲就其共同商业化，并共享利润。同时，信达保留在大中华区地区的权利。 在恒瑞医药与BMS的交易中，恒瑞医药也表示，拥有共同开发特定项目的选择权，并且有机会与BMS在全球范围内共同开展特定的商业化活动。 有医药行业人士对第一财经记者表示，创新药企在对外授权过程中，能否参与共同开发及共同商业化，仍考...

复星医药公告，控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司自研的帕妥珠单抗注射液上市注册申请获国家药品监督管理局批准。该药品适应症覆盖原研帕妥珠单抗注射液在中国已获批的所有适应症，包括早期乳腺癌和转移性乳腺癌的治疗。该药品系本集团自主研发的帕妥珠单抗生物类似药，除本次获批外，已获美国食品药品监督管理局（FDA）、欧盟委员会的上市批准，并已获加拿大卫生部上市申请受理。

日本内阁势将批准3.11万亿日元的补充预算 2026-05-29 17:27:50 来源： 同花顺7x24快讯 分享 日本内阁势将批准3.11万亿日元的补充预算。(财联社)

*ST华嵘发布更正公告，公司股票进入退市整理期交易的起始日为2026年6月1日，退市整理期为15个交易日，预计最后交易日为2026年6月22日。如证券交易日期出现调整，公司退市整理期最后交易日期随之顺延。如公司股票在退市整理期内全天停牌的，停牌期间不计入退市整理期，预计的最后交易日期将顺延。全天停牌天数累计不超过5个交易日。

文章提及标的 宁波远洋 -- 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

Fang Zheng Costco ( COST ) saw record fuel sales volumes in the third quarter as shoppers flocked to its gas stations to pay less at the pump amid high oil prices driven by the Iran war. "All three four-week fiscal periods of the quarter set successive all-time company volume sales records, with the final five weeks of the quarter becoming our top 5 volume weeks ever," Costco ( COST ) CEO Ron Vachris said during an earnings call on Thursday. "The high consumer price sensitivity, which fueled these record volumes, also drove many members to use our gas stations for the very first time in Q3," he noted, adding that "this will drive even greater loyalty with these members in the future." Costco ( COST ) reported Q3 comparable sales growth of 9.8%, well above the consensus estimate of 7.8%. Gas price inflation positively impacted comp sales by about 2.2%. "Gas prices are very much on members' minds," said Costco ( COST ) CFO Gary Millerchip, as gas is now a bigger percentage of a member's total spend in the month because of higher prices. "We've widened our gaps in terms of price to make sure we're there for our members." More on Costco Costco Wholesale (COST) Q3 2026 Earnings Call Transcript Costco Wholesale 2026 Q3 - Results - Earnings Call Presentation Costco Q3 Earnings Preview: Great Business With Limited Upside Costco outlines 30-plus net new openings per year

At the time, officials estimated the cost at between £17m and £700m - however, that top figure would only apply if all of the waste was dug up and transported elsewhere, which is not what Muir's department is planning to do.

The trillion-dollar company that Warren Buffett helped build, Berkshire Hathaway (BRKA 0.27%)(BRKB 0.53%), has entered uncharted territory. For the first time in well over half a century, the Oracle of Omaha, who outperformed the benchmark S&P 500 (^GSPC +0.58%) by more than 6,000,000% over six decades, is not at the helm. But just because Buffett retired as CEO on Dec. 31 and handed the reins to his protégé, Greg Abel, it doesn't mean his legacy isn't lasting. Two weeks ago, an update of Warren Buffett's $786 million "secret" portfolio revealed that a time-tested investment and proven millionaire-maker is still the No. 1 holding. The Oracle of Omaha's "secret" portfolio is nothing like Berkshire's $333 billion portfolio In 1998, Berkshire Hathaway acquired General Re in an all-stock deal valued at approximately $22 billion. Though the catalyst of this deal was General Re's reinsurance operations, this wasn't the only puzzle piece of this acquisition. General Re also owned a specialty investment firm, New England Asset Management (NEAM). Upon completion of the deal, NEAM became a subsidiary of Berkshire Hathaway. Although Buffett didn't oversee NEAM's portfolio in the same way that he directed traffic for Berkshire's $333 billion investment portfolio, NEAM's assets are, ultimately, part of Berkshire. This connection is what makes NEAM Buffett's "secret" portfolio. Institutional investors with at least $100 million in assets under management are required to file a Form 13F with regulators every quarter, detailing their buying and selling activity. NEAM handily exceeds this threshold, allowing investors to track trades in this under-the-radar portfolio. New England Asset Management's latest 13F shows 99 holdings, with a big emphasis on exchange-traded funds (ETFs), preferred stocks, and time-tested dividend stocks. This is in stark contrast to Berkshire's concentrated investment portfolio. This top holding is a surefire moneymaker (with a catch) Sitting atop the pedes...

Key Points Although Warren Buffett retired as Berkshire Hathaway's CEO on Dec. 31, his legacy is lasting. The Oracle of Omaha's "secret" portfolio, which can be traced to a Berkshire acquisition in 1998, is highly diverse and ETF-oriented. The top holding of Buffett's secret portfolio tracks an index that hasn't generated a negative rolling 20-year total return (including dividends) since 1900. 10 stocks we like better than SPDR S&P 500 ETF Trust › The trillion-dollar company that Warren Buffett helped build, Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB), has entered uncharted territory. For the first time in well over half a century, the Oracle of Omaha, who outperformed the benchmark S&P 500 (SNPINDEX: ^GSPC) by more than 6,000,000% over six decades, is not at the helm. But just because Buffett retired as CEO on Dec. 31 and handed the reins to his protégé, Greg Abel, it doesn't mean his legacy isn't lasting. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Two weeks ago, an update of Warren Buffett's $786 million "secret" portfolio revealed that a time-tested investment and proven millionaire-maker is still the No. 1 holding. The Oracle of Omaha's "secret" portfolio is nothing like Berkshire's $333 billion portfolio In 1998, Berkshire Hathaway acquired General Re in an all-stock deal valued at approximately $22 billion. Though the catalyst of this deal was General Re's reinsurance operations, this wasn't the only puzzle piece of this acquisition. General Re also owned a specialty investment firm, New England Asset Management (NEAM). Upon completion of the deal, NEAM became a subsidiary of Berkshire Hathaway. Although Buffett didn't oversee NEAM's portfolio in the same way that he directed traffic for Berkshire's $333 billion investment portfolio, NEAM's assets are, ultimately, part of Berkshire. Th...

截至2026年一季度，资金总量前十的城市存款余额总量均超过了5万亿大关，其中4个城市超过了10万亿。 城市“金融机构各项存款余额”，又叫“资金总量”，反映了一个城市对资金的吸附能力，也是衡量这个城市综合实力和发展潜力的重要依据。 第一财经记者梳理各大城市金融机构各项存款余额发现，截至2026年一季度，资金总量前十的城市存款余额总量均超过了5万亿大关，其中4个城市超过10万亿。 3月末，北京市本外币各项存款余额31.7万亿元，同比增长9.6%，比年初增加1.1万亿元。其中，外币存款余额1201.6亿美元。 北京是金融监管中心，拥有北交所在内的金融要素交易平台，聚集了全国最多的大型金融机构、中央企业，还有大量的大型跨国公司地区总部以及在北京成长起来的大型民企总部和从外埠迁入北京的企业总部，上市公司数量位居全国第一，总市值亦遥遥领先。 上海则坐拥上交所和一大批金融机构，总部经济十分突出，大型跨国公司地区总部数量居全国首位。3月末，上海全市中外资金融机构本外币存款余额24.87万亿元，同比增长13.0% 作为强一线城市，北京和上海均是名副其实的全国中心城市，两城的资金总量遥遥领先其他城市。整体来看，上海和北京现代服务业、高新技术产业、新兴产业发达，总部经济突出，集聚的资金多。 京沪之后，位于华南地区的深圳存款余额也超过了15万亿，位居第三。数据显示，3月末，深圳全市金融机构（含外资）本外币存款余额152636.36亿元，同比增长9.3%。作为深交所的所在地，深圳也聚集了大批金融机构、高新技术企业以及上市公司。 根据媒体报道，今年2月6日，随着卓正医疗、大族数控在港股挂牌，深圳辖区上市公司总数突破600家。这一里程碑“节点”是深圳“科技-产业-金融”深度融合的最新发展成果。600家深圳上市公司中，境内426家、境外174家。新增A股企业多登陆科创板与创业板，科技创新成为核心聚焦方向。受益于资本市场包容性提升、流动性活跃，一系列“技术硬”、代表智能制造的深圳科技企业加速筹备上市发行，以谋求全球化、跨越式发展机遇。 广州的数据显示，3月末，全市金融机构本外币存贷款余额18.87万亿元，同比增长8.7%，增速比去年末提升2.3个百分点。存款余额突破10万亿元，增长11.2%。广州也成为继北上深之后，第4个存款余额破10万亿大关的城市。 杭州的本外币存款余额超过了8.5万亿，达856...

China's low-key presence at Asia defence forum a lost opportunity, Australia says Reuters

中国生物制药公告，集团附属公司正大天晴药业集团股份有限公司独家引进的国家1类创新药纳地美定(Naldemedine)（通用名称：甲苯磺酸纳地美定片，商品名称：欣璞落 /Symproic ）已获得中国国家药品监督管理局(NMPA)批准上市，用于治疗成人因阿片类药物引起的便秘(OIC)。

格隆汇5月29日｜港股5月交易今日正式收官，港股三大指数呈现上半月小幅冲高，下半月持续回调行情。本月三大指数涨跌互现，恒生科技指数表现优于恒指，本月恒生指数跌2.3%报25182点，国企指数跌2.95%报8425点，恒生科技指数小幅上涨0.27%报4884点。尽管指数平淡，但结构分化极为显著——资金从传统互联网平台全面涌入AI算力、半导体等“硬核”方向。 板块方面，存储半导体板块为5月最强主线，芯智控股涨73.22%，兆易创新涨近58%，澜起科技涨52.79%，华虹半导体涨41.37%，纳芯微涨31%，这些个股均创下历史新高！另外，中芯国际涨15%同样逼近高价。光通信，手机产业链、商业航空、锂电池、内房股等板块相对活跃。其中，舜宇光学涨31.55%，中国海外发展涨17.62%，长飞光纤涨14.17%并且连涨7个月。 大型科技股方面，百度涨9.52%，网易涨8.38%，快手涨6.15%，美团跌11.77%，腾讯跌7.6%，阿里巴巴跌4%，小米跌3.38%，京东跌2.4%。此外，受业绩与AI推动，联想集团月末加速上涨，股价大涨105.6%创历史新高！ 根据中信证券、海通国际、国元证券等多家机构的观点，市场对6月港股展望的核心共识是：短期存在“拔估值”窗口，但需要警惕解禁高峰带来的流动性压力，整体呈现“防守反击”的震荡格局。(格隆汇)

伊朗冲突再度搅动 5 月全球债券市场。交易员押注各国央行将加息，推动债券收益率攀升至数十年高位；而后和平谈判出现进展、经济数据走弱，收益率又应声大幅回落。 即便冲突彻底结束会立刻缓解市场压力、降低全球各国政府的融资成本，但 5 月债市的剧烈波动也凸显出，投资者对通胀走势与不断高企的公共债务始终心存担忧。 美债市场剧烈波动 受伊朗局势影响，规模达 28 万亿美元的美国国债市场遭遇动荡。5 月 20 日， 美国 30 年期国债收益率飙升至 5.2% 左右 ，创下 2007 年以来新高。 和平谈判陷入停滞、油价重回每桶 110 美元上方，叠加美国通胀数据居高不下，成为全球债券遭抛售的主要诱因。 英国债券收益率创下二三十年新高，日本部分债券收益率触及历史峰值，德国 10 年期国债收益率也升至 2011 年以来最高水平。 富兰克林邓普顿欧洲固定收益主管戴维・赞恩表示：“市场担忧，通胀高企的持续时间会超出此前预期。” 市场逐步降温，显现增长隐忧 美伊双方传出谈判进展，油价随之回落；同时欧洲等地区经济数据疲软，大幅削弱了央行大幅加息的可能性，债券融资成本由此走低。 上周公布的数据显示，受能源价格上涨拖累，5 月欧元区经济活动创下两年半以来最大降幅。 资产管理公司坎德拉姆首席投资官尼古拉斯・福雷斯特称：“当前收益率水平对投资者已具备吸引力。经济增速放缓，整体利好债券市场。” 美债走势独树一帜 此前欧元区、英国、日本等能源进口经济体一直是债券抛售潮的重灾区，而 5 月美国债市表现明显弱于其他地区 。 4 月 30 日至 5 月 29 日，美国 10 年期国债收益率上行 6 个基点，同期德国国债收益率则下行 6 个基点。 欧洲经济数据降温，市场加息预期随之减弱；而在人工智能领域投资热潮的加持下，美国经济依旧保持强劲。 交易商已彻底打消美联储今年降息的预期，甚至一度押注美联储将在 12 月累计加息 25 个基点。 周四数据显示，美联储青睐的核心通胀指标 4 月同比上涨 3.8%，创下三年来最大同比涨幅。 对英国国债市场而言，5 月依旧惊心动魄。自 2022 年利兹・特拉斯执政引发市场危机后，英国国债便极易遭遇抛售行情。 责任编辑：郭明煜

全球投资者今年疯狂涌入三星电子和SK海力士股票交易，推动这两只内存股分别上涨了147%和245%，但飙升的股价给一些基金带来了意想不到的麻烦。由于这两家公司股价屡创新高，已经触及了一些基金单只股票持仓比例上限10%的限制，迫使这些基金抛售这两只股票。苏黎世的GAM投资管理公司和新加坡的Jupiter资产管理公司据悉正是触发此类抛售的公司之一，其已经无奈调整了投资组合。这一被迫抛售无疑凸显了当前内存市场的拥挤程度，也可能进一步加大波动性。截至周四，全球投资者净抛售了价值636亿美元的韩国股票，这是自1999年有数据以来最大的单月抛售量。其中，三星和SK海力士今年合计净流出资金达586亿美元。（财联社）

万华化学公告，公司董事、常务副总裁华卫琦于2026年5月29日通过集合竞价交易方式，以自有资金买入公司A股股票8000股，买入均价为73.52元/股。此次交易后，华卫琦持有公司股票总数增至15000股。华卫琦表示，此次增持是基于对公司未来发展的看好，并承诺自买入之日起六个月内不再卖出所购股票。

记者29日获悉，中央网信办近日印发通知称，在全国范围内启动为期2个月的“清朗·优化营商网络环境整治恶意炒作涉企信息”专项行动，集中整治恶意炒作涉企侵权信息乱象，从严从快清理处置涉企侵权信息、账号，督促网站平台扎实履行主体责任，健全涉企信息内容管理机制，加大涉企侵权信息处置力度，进一步优化营商网络环境。 专项行动聚焦恶意炒作涉企信息、诋毁抹黑企业、牟取非法利益、侵犯企业家个人权益等四类突出问题开展整治，包括恶意集纳涉企负面信息，泛化异化炒作企业经营问题或产品质量问题；利用AI生成涉企虚假不实信息，恶意抹黑诋毁企业、企业家；发布涉企负面信息后，向企业索要“删帖费”“撤稿费”；炒作企业家个人隐私等。 根据工作要求，专项行动将压实主体责任，指导督促网站平台加强涉企侵权信息发现力、研判力、处置力，强化AI生成合成信息、网络测评活动信息管理，加大账号、MCN机构管理力度；对经依法处置的网站、平台和账号适时曝光，强化警示震慑。(新华社)

Alistair Berg/DigitalVision via Getty Images U. S. equity futures remained steady Friday morning, after a record-breaking day on Wall Street. Market sentiment is supported by strong tech earnings and diplomatic progress in the Middle East. However, ongoing market challenges are limiting overall trading volumes ahead of key economic updates. Here are some of Friday's biggest stock movers: Biggest stock gainers Dell Technologies ( DELL ) +38.4% - Shares advanced after posting record Q1 revenue of $43.8 billion (+88% YoY) and massive non-GAAP EPS of $4.86. The company also upped its full-year forecast for fiscal 2027 , as it now sees revenue between $165B and $169B, up from a prior range of $138B to $142B. Analysts were expecting $142.12B in full-year revenue. Adjusted earnings are expected to be $17.90 per share at the midpoint, well above the $13.12 analysts had anticipated. For the upcoming second quarter of fiscal 2027, Dell said it expects revenue to be between $44B and $45B, with the $44.5B midpoint well above the $35.06B analysts were expecting. Adjusted earnings for the second quarter are expected to be $4.80 per share, well above the $2.99 analysts were anticipating. Hewlett Packard Enterprise ( HPE ) +19.1% - Shares gained momentum in sympathy with Dell's blockbuster numbers and a major pre-earnings price target hike to $37 from $27 (retaining an Overweight rating). Analysts noted strong enterprise refresh activity and high demand for networking/cloud solutions. A clear path to a $3.00 EPS target for fiscal 2028 suggests a promising mid-to-high-teens earnings CAGR before Q2 earnings on June 1. NetApp ( NTAP ) +15.2% - Shares advanced after delivering strong Q4 earnings , beating top- and bottom-line expectations with an adjusted EPS of $2.43 on revenue of $1.95 billion, driven by robust expansion in high-margin all-flash storage arrays. NetApp anticipates Q1 2027 sales of $1.75B to $1.9B, surpassing the $1.67B forecast. Adjusted earnings are projected between...

Key Points Ethereum is crypto's largest and most important venue for decentralized finance (DeFi). Hyperliquid has a small but quickly growing DeFi ecosystem. However, it's facing a lot of competition. 10 stocks we like better than Hyperliquid › Investors are always coming up with new narratives about new challengers rising and unseating the market's entrenched leaders. Today, there's a narrative that suggests Hyperliquid (CRYPTO: HYPE), a blockchain and decentralized crypto exchange for trading a type of derivative called perpetual futures, just might become the next Ethereum (CRYPTO: ETH). That's more plausible than ever, considering that Hyperliquid spent its first year of existence bulldozing its competition in decentralized derivatives before starting to expand into the broader decentralized finance (DeFi) segment. DeFi is Ethereum's main reason for being, and in that respect it's way out in front. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » But becoming the next Ethereum is a big task. That network grew to be plenty big, but the more important factor is that it invented the very category it grew into. Whether Hyperliquid can follow that arc depends on several different factors, so let's analyze them and see if it has a shot at unseating the crypto sector's reigning DeFi champion. This chain has the energy of a unicorn tech start-up Hyperliquid's grip on the decentralized perpetuals market is hard to overstate. As of April 2026, it controlled more than 70% of open interest (OI) across decentralized perpetual markets, processing upward of $180 billion in monthly volume, which is more than every other on-chain derivatives platform combined. Perpetual futures contracts are essentially a way of making a leveraged bet on the direction that an asset is moving constantly, rather than using other...

翔港科技公告，公司拟向不特定对象发行可转换公司债券募集资金不超过4.78亿元，扣除发行费用后的募集资金净额将用于翔港科技彩盒包装扩产项目、翔港科技研发中心升级项目及补充流动资金。 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

格隆汇5月29日｜瑞银将Snowflake的目标价从210美元上调至325美元，维持“买入”评级。(格隆汇)

小摩：降理想汽車-W(02015)目標價至56港元 重申“減持”評級 作者 智通財經 Investing.com 香港 - 股市報價& 財經新聞

记者29日从农业农村部了解到，全国夏粮收获过两成。 农业农村部有关负责人表示，去年各地千方百计应对罕见秋季连阴雨影响，稳住了冬小麦面积，追回了苗情。据农业农村部农情调度显示，截至5月28日，全国夏粮收获过两成，冬小麦收获已近两成，其中西南接近尾声、长江中下游过八成，黄淮海即将开始大面积收获。全国冬油菜收获过九成，进入扫尾阶段。 夏粮包括夏收的谷物、豆类和薯类。其中夏收谷物主要包括小麦、大麦等；夏收豆类主要包括蚕豆、豌豆和胡豆；薯类包括马铃薯和甘薯。(新华社)

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Brookfield Corporation BN is a diversified investment company. The Zacks Consensus Estimate for its current year earnings has been revised 10.7% downward over the last 60 days. CNB Financial Corporation CCNE is a bank holding company for CNB Bank. The Zacks Consensus Estimate for its current year earnings has been revised 7.1% downward over the last 60 days. Cass Information Systems, Inc. CASS is a payment and information processing services provider.The Zacks Consensus Estimate for its current year earnings has been revised 14.2% downward over the last 60 days. View the entire Zacks Rank #5 List. 5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%. Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cass Information Systems, Inc (CASS) : Free Stock Analysis Report CNB Financial Corporation (CCNE) : Free Stock Analysis Report Brookfield Corporation (BN) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.